Autoimmune thyroid disorders—An update

  • Manorama Swain
  • Truptirekha Swain
  • Binoy Kumar Mohanty


Background: Autoimmune thyroid disease (AITD), a common organ specific autoimmune disorder is seen mostly in women between 30–50 yrs of age. Thyroid autoimmunity can cause several forms of thyroiditis ranging from hypothyroidism (Hashimoto’s thyroiditis) to hyperthyroidism (Graves’Disease). Prevalence rate of autoimmune mediated hypothyroidism is about 0.8 per 100 and 95% among them are women. Graves’ disease is about one tenth as common as hypothyroidism and tends to occur more in younger individuals. Both these disorders share many immunologic features and the disease may progress from one state to other as the autoimmune process changes. Genetic, environmental and endogenous factors are responsible for initiation of thyroid autoimmunity. At present the only confirmed genetic factor lies in HLA complex (HLA DR-3) and the T cell regulatory gene (CTLA 4). A number of environmental factors like viral infection, smoking, stress & iodine intake are associated with the disease progression. The development of antibodies to thyroid peroxidase (TPO) thyroglobulin (TG) and Thyroid stimulating hormone receptor (TSH R) is the main hallmark of AITD. Circulating T Lymphocytes are increased in AITD and thyroid gland is infiltrated with CD4+ and CD8+ T Cells. Wide varieties of cytokines are produced by infiltrated immune cells, which mediate cytotoxicity leading to thyroid cell destruction. Circulating antibodies to TPO and TG are measured by immunofluorescense, hemagglutination, ELISA & RIA. TSHR antibodies of Graves’ disease can be measured in bioassays or indirectly in assays that detect antibody binding to the receptor.

Key Words

Autoimmune thyroid disease thyroid peroxidase antibodies Thyroglobulin antibodies and TSHR antibodies 


  1. 1.
    Canaris, G.J., Manowitz, N.R., Mayor, G.M. and Ridgway, E.C. (2000) The Colorado thyroid disease prevalence studies. Arch. Int. Med. 160, 526–534.CrossRefGoogle Scholar
  2. 2.
    J. Larry J. and A.P. Weetman (2001) Disorders of the Thyroid gland, In: Harrison’s Principles of Internal Medicine, 15th Edn, Vol.2, Eds. E. Brunwald and A. Fauci Mc Graw-Hill Publication, USA. p 2060–2084.Google Scholar
  3. 3.
    Marcocci, C., Chiovato, L. (2000) Thyroid-directed antibodies, In: The Thyroid: A Fundamental and Clinical Text. 8th ed. Eds. Braverman LE, Utiger RD, Lippincott Williams & Wilkins, Philadelphia. p 414–31.Google Scholar
  4. 4.
    Weetman, A.P., McGregor, A.M. (1994) Autoimmune thyroid disease: Further developments in our understanding. Endocr. Rev. 15, 788–830.PubMedCrossRefGoogle Scholar
  5. 5.
    Brix, T.H., Kyvik, K.O., Christensen, K., Hegedus, L. (2001) Evidence for a major role of heredity in Graves’ disease: a population-based study of two Danish Twin cohorts. J. Clin. Endocrinol. Metab. 86, 930–934.PubMedCrossRefGoogle Scholar
  6. 6.
    Ban Y., Tomer, Y. (2003) The contribution of immune regulatory and thyroid specific genes to the etiology of Graves’ and Hashimoto’s disease. Autoimmunity. 36(6–7), 367–79.PubMedCrossRefGoogle Scholar
  7. 7.
    Weetman, A.P. (2000) Endocrinology. In: Handbook of HLA and Disease, 2nd Edn. Eds: Lechler RI, Warrens A. Academic Press, London.Google Scholar
  8. 8.
    Onuma, H., Ota, M., Sugenoya, A., Inoko, H. (1994) Association of HLA-DPB-0501 with early-onset Graves’ disease in Japanese. Hum Immunol 39, 195–201.PubMedCrossRefGoogle Scholar
  9. 9.
    Tandon, N., Mehera, N.K., Taneja, V., Vaidya, M.C., Kochupillai, N. (1990) HLA antigens in Asian Indian Patients with Graves’ disease. Clin Endocrinol (oxf) 33, 21–26.CrossRefGoogle Scholar
  10. 10.
    Omar, M.A., Hammond, M.G., Desai, R.K., Motala, A.A., Aboo, N., Seedat, M.A. (1990) HLA class I and II antigens in South African blacks with Graves’ disease. Clin Immunopathol 54, 98–102.CrossRefGoogle Scholar
  11. 11.
    Furugaki K. Shirasawa S, Ishikawa N, Ito K, Kobota S, Kuma K, Tamai H, Akamizu T, Hiratani H, Tanaka M, Sasazuki T, (2004) Association of the T-cell regulatory gene CTLA4 with Graves’ disease and autoimmune thyroid disease in the Japanese. J. Hum. Genet. 49 (3), 166–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Ueda, H., Howson, J.M., Esposito, L., (2003) Association of the T-Cell regulatory gene CTLA-4 with susceptibility to autoimmune disease. Nature, May 29. 423(6939), 506–11.Google Scholar
  13. 13.
    Pei-Win Wang, Rue-Tsuan, Liu, Suh-Hang Hank Juo et al, (2004) Cytotoxic T Lymphocyte-Associated Molecule-4 Polymorphism and Relapse of Graves’ Hyperthyroidism after Antithyroid withdrawal, The J. Clin. Endocrinol. Metab. Vol.8 No. 1, 169–173.CrossRefGoogle Scholar
  14. 14.
    Noel, R.R., Raphael, B. and Burek, C.L. (2002). Iodine: an environmental trigger of thyroiditis. Autoimmun. Rev. Feb Vol. 1 (1–2), 97–103Google Scholar
  15. 15.
    Tomer, Y., Davies, T.F. (1993) Infection, thyroid disease and autoimmunity. Endocr. Rev. 14, 107–120.PubMedCrossRefGoogle Scholar
  16. 16.
    Jaspan, J.B., Sullivan, K., Garry, R.F. (1996) The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves’ disease. J. Clin. Endocrinol. Metab. 81, 2271–2279.PubMedCrossRefGoogle Scholar
  17. 17.
    Bartalena, L., Bogazzi, F., Tanda, M.L. (1995). Cigarete smoking and the thyroid. Eur. J. Immunol. 133, 507–512.Google Scholar
  18. 18.
    Strieder, T.G., Prummel, M.F. (2003) Risk factors for and prevalence of thyroid disorders in a cross sectional study among healthy female relatives of patients with autoimmune thyroid disorder. Clin Endocrinol (OXF) Sep, 59(3), 396–401.CrossRefGoogle Scholar
  19. 19.
    Prasad KV, Prabhakar BS, (2003) Apoptosis and autoimmune disorders, Autoimmunity, 36(6–7), 323–30.PubMedCrossRefGoogle Scholar
  20. 20.
    McLachian, S.M., Rapport B. (1992) The molecular biology of thyroid peroxidase: Cloning, expression and role as autoantigen in autoimmune thyroid disease. Endo. Rev. 13, 192–206.CrossRefGoogle Scholar
  21. 21.
    McIntosh, R., Waston, P, Weetman A. (1998) Somatic hypermutation in autoimmune thyroid disease. Immunol. Rev. 162, 219–231.PubMedCrossRefGoogle Scholar
  22. 22.
    Silva, L.M., Chavej, J., Canalli, M.H., Zanetti, C.R. (2003) Determination of IgG sub classes and avidity of antithyroid peroxidase antibodies in patients with subclinical hypothyroidism—a comparison with patient with overt hypothyroidism. Horm Res. 59(3), 118–24.PubMedCrossRefGoogle Scholar
  23. 23.
    malthiery, Y., Lissitzky, S. (1987) Primary structure of human Thyroglobulin deduced from the sequence of its 8848-base complementary DNA. Eur. J. Biochem. 105, 491–498.CrossRefGoogle Scholar
  24. 24.
    Canayanniotis, G., Rao, V.P. (1997) Searching for pathogenic epitopes in Thyroglobulin: Parameters and caveats. Immunol. Today. 18, 83–88.CrossRefGoogle Scholar
  25. 25.
    Brown, T.R., Zhao, G., Palmer, K.C. (1997): Thyroid injury, autoantigen availability and the initiation of autoimmune thyroiditis. Autoimmunity. 27, 1–12.Google Scholar
  26. 26.
    Collison, K.S., Banga, J.P., Barnett, P.S. (1991) Autoantibody stimulation of the human thyrotropin receptor: Regulation of adenlyate cyclase activity, Thyroglobulin and thyroid peroxidase mRNA levels in primary cultures of Graves’ thyroid tissue. Clin. Exp. Immunol. 86, 61–5.PubMedGoogle Scholar
  27. 27.
    Prabhakar, B.S., Fan J.L., Seetharamaiah, G.S. (1997) Thyrotropin-receptor-mediated diseases: A paradigm for receptor autoimmunity. Immunol. Today. 18, 437–442.PubMedCrossRefGoogle Scholar
  28. 28.
    Ajjan, R.A., Findlay, C., Metcalfe, R.A. (1998) The modulation of the human sodium iodine symporter activity by Graves’ disease sera. J. Clin. Endocrinol. Metab. 83, 1217–1221.PubMedCrossRefGoogle Scholar
  29. 29.
    Stassi G, De Maria R, (2002), Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat. Rev. Immunol. 2(3), 195–204.PubMedCrossRefGoogle Scholar
  30. 30.
    Smallridge, R.C. (1996) Postpartum thyroid dysunction: A frequently undiagnosed endocrine disorder. Endocrinologist. 6, 44–50.Google Scholar
  31. 31.
    Nilsson, M., Husmark, J., Bjokman, U., Ericson, L.E. (1998) Cytokines and thyroid epithelial integrity: Interleukin-1 a induces dissociation of the junctional complex and paracellular leakage in filter-cultured human hydrolytes. J. Clin. Endocrinol. Metab. 83, 945–952.PubMedCrossRefGoogle Scholar
  32. 32.
    Weetman, A.P., Ajjan, R.A., Watson, P.F. (1997) Cytokines and Graves’ disease. Baillieres Clin Endocrinol Metab 11:481–497.PubMedCrossRefGoogle Scholar
  33. 33.
    Weetman, A.P., Freeman, M.A., Borysiewicz, L.K. (1990) Functional analysis of intercellular adhesion molecule-1 expressing human thyroid cells. Eur. J. Immunol. 20, 271–275.PubMedCrossRefGoogle Scholar
  34. 34.
    Wu, Z., Podack, E.R., McKenzie, J.M. (1994) Perforin expression by thyroid infiltrating T cells in autoimmune thyroid disease. Clin. Exp. Immunol. 98, 470–477.PubMedGoogle Scholar
  35. 35.
    Giordano, C., Stassi, G., De, Maria, R., (1997): Potential involvement of Fas and its Ligand on the pathogenesis of Hashimoto’s thyroiditis. Science. 275, 960–963.PubMedGoogle Scholar
  36. 36.
    Chiovato, L., Bassi, P., Santini, F. (1993) Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J. Clin. Endocrinol. Metab. 77, 1700–1705.PubMedCrossRefGoogle Scholar
  37. 37.
    Simons, P.J., Delemarre, F.G.A., Drexhage, H.A. (1998) Antignen-presenting dendritic cells as regulators of the growth of hydrolytes: A role of interleukin-1b and interleukin-6. Endocrinology. 139, 148–3156.CrossRefGoogle Scholar
  38. 38.
    Hegedus, L., Hansen, J.M., Feldt-Rasmussen, U., Hansen, B.M., and Moier-Madsen, M. (1991). Influence of thyroxine treatment on thyroid size and anti-thyroid peroxidase antibodies in Hashimoto’s thyroiditis. Clin. Endocrinol. 35, 235–238.CrossRefGoogle Scholar
  39. 39.
    Volpe R. (1994) Evidence that the immunosuppressive effects of antithyroid drugs are mediated through actions on the thyroid cell, modulating thyrocyte-immunocyte signaling. Thyroid. 4, 217–221.PubMedGoogle Scholar
  40. 40.
    Lee S, Scherberg N, DeGroot LJ, et al. (1998) Induction of oral tolerance in human autoimmune thyroid disease. Thyroid. 8, 229–234.PubMedGoogle Scholar
  41. 41.
    Baker, J.R. Jr., Fosso, C.K. (1993) Immunological aspects of cancers arising from thyroid follicular cells. Endocr. Rev. 13, 729–746.CrossRefGoogle Scholar
  42. 42.
    Matsuzuka, F.M., Miyauchi, A., Katyama, S. (1993), Clinical aspects of primary thyroid lymphoma: Diagnosis and treatment based on our experience of 119 cases. Thyroid. 3, 93–99.PubMedCrossRefGoogle Scholar
  43. 43.
    Giani, C., Fierabracci, P., Bonacci, R. (1996) Relationship between breast cancer and thyroid disease: Relevance of autoimmune thyroid disorders in breast malignancy. J. Clin. Endocrinol. Metab. 81, 990–994.PubMedCrossRefGoogle Scholar

Copyright information

© Association of Clinical Biochemists of India 2005

Authors and Affiliations

  • Manorama Swain
    • 1
  • Truptirekha Swain
    • 2
    • 4
  • Binoy Kumar Mohanty
    • 3
  1. 1.Department of BiochemistryM.K.C.G. Medical CollegeBerhampur
  2. 2.Department of PharmacologyM.K.C.G Medical CollegeBerhampur
  3. 3.Department of EndocrinologyM.K.C.G Medical CollegeBerhampur
  4. 4.S.C.B. Medical CollegeCuttack

Personalised recommendations